SOURCE: Market Pulse

October 31, 2007 08:30 ET

Market Pulse Breaking News Alert for Wednesday, October 31, 2007: ZMS - Zecotek Announces First Commercial Production Run of New-Generation Solid-State Photo Detectors!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA--(Marketwire - October 31, 2007) - Market Pulse News Alert for this AM, Stocks to Watch are: Zecotek Medical Systems Inc. (TSX-V: ZMS), Texas Roadhouse Inc. (NASDAQ: TXRH), Sepracor Inc. (NASDAQ: SEPR) and Microsoft Corp. (NASDAQ: MSFT).

Investors need to be watching Zecotek Medical Systems Inc. (TSX-V: ZMS) this AM! Zecotek Medical Systems is a photonics company that develops high-performance crystals, photo detectors, medical lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. The company has three distinct operating divisions: imaging, lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek has developed two significant photonic technologies with the potential to revolutionize the $15 billion medical diagnostics industry. With core competencies in lasers, optoelectronics and crystal growth, Zecotek's Singapore Lab is focused on introducing creative laser solutions to this growing industry. The annual revenue generated by the US medical laser systems market alone, has more than doubled in the past five years and reached $2.5 billion in 2006. ZMS has successfully developed a compact, color 3D display prototype that offers multiple viewers with true volumetric visualization and exhibit depth and parallax over a wide viewing angle. The unique applications of photonics continue to emerge. Those which are established as economically important applications for semiconductor photonic devices include optical data recording, fiber optic telecommunications, laser printing (based on xerography), displays, and optical pumping of high-power lasers. The potential applications of photonics are virtually unlimited and include chemical synthesis, medical diagnostics, on-chip data communication, laser defense, and fusion energy to name several interesting additional examples. Zecotek has a proven track record of securing licensing agreements with industry leaders. The company is creating shareholder value by commercializing novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. ZMS has partnered with the University of Washington to develop a proprietary PET/MRI scanning device, which has the potential to set a new standard in medical imaging. Northrop Grumman has signed a 20-year exclusive agreement to license ZMS' LFS scintillation crystal material. Zecotek recently announced that it has signed a letter of intent with Fujikura Ltd. of Japan to negotiate terms of a proposed business partnership which would feature the manufacture and distribution of certain technologies and products, including Zecotek's new line of fiber lasers and a detector block consisting of Zecotek's proprietary solid-state photo detectors and LFS scintillation crystals. The company is transitioning from a purely research and development company to commercializing its key photonics technology. ZMS is poised to become a significant player in the photonics and medical diagnostics industry! Zecotek Medical Systems just had excellent news out in a press release before today's opening bell announcing its first commercial production run of new-generation solid-state photo detectors! Investors need to go to the company's website www.zecotek.com and review its exciting technology's potential! Investors should be watching this one closely!

Zecotek Medical Systems Inc. (TSX-V: ZMS) today announced that the Malaysian Institute for Micro-electronics Systems (MIMOS), Malaysia's premier center for advanced micro-electronics technology and manufacturing based in Kuala Lumpur, has successfully completed the first commercial production run of the company's new-generation Micro-pixel Avalanche Photo Diodes (MAPD) solid-state photo detectors. First-run production samples are being delivered to key customers in both medical imaging and high-energy physics for further testing.

"We are extremely impressed by the production capabilities of MIMOS," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "The first production runs of our MAPD-2 and MAPD-3 were produced with excellent yields and at a cost that gives Zecotek a significant advantage over competing products. We are confident that with its cost and performance advantages, Zecotek's MAPD will rapidly become the gold standard in photo-detection."

Zecotek's patented MAPDs have been designed in several configurations to offer significant performance and cost advantages over the current photo-multiplier vacuum tubes (PMT) and existing solid state photo-detectors. The MAPD-2 addresses specific, high-demand requirements in high-energy physics such as particle accelerators where PMTs are vulnerable to the magnetic environment created by the superconducting magnets used in the collimation of particle tracks. The MAPD-3 meets required specifications for advanced, high resolution PET (Positron Emission Tomography) scanners and gamma camera applications, particularly when matched with Zecotek's patented LFS scintillation materials. Zecotek is focused on bringing to market cost effective, mass produced MAPDs with consistent key performance parameters, such as high linearity and timing resolution, essential for "time of flight" design configurations used in next generation, high resolution PET medical scanners.

Pre-production MAPDs, developed in Zecotek's own labs, were successfully tested by a number of third-party entities including the University of Washington, which demonstrated that Zecotek's MAPDs, in combination with its patented LFS scintillation crystal, outperformed current PMTs in critical imaging parameters.

"Our laboratory has been using Zecotek's prototype MAPD-2 and MAPD-3 devices in our designs for high-resolution detectors for pre-clinical positron emission tomography (PET) scanners and a PET insert for magnetic resonance (MRI) scanners," reported Dr. Thomas Lewellen, Professor of Radiology and Director of Physics and Instrumentation Development in Nuclear Medicine at the University of Washington and a member of Zecotek's Advisory Board. "We look forward to implementing the improved, production version of the MAPD in our scanning systems. We believe that a solid-state replacement for photomultipliers, such as the MAPD, is essential for a wide range of important detector design advances and for future PET development in particular."

Most solid state photo-detectors developed in the past few years are generally based on the MAPD-1 design concept, originally developed and patented by Prof. Zair Sadygov, Chief Scientist at Zecotek. However, Zecotek has built on this design concept and completed the development of the MAPD-2 and MAPD-3, versions which are compatible with large scale manufacture without compromising the operational characteristics requested by the imaging industries.

PMT based photo-detection devices form a major cost component in the US$1 billion market for PET and PET-CT scanners, representing approximately one-third of the cost of each unit. Existing PMTs are also key components of medical inspection devices used in blood analysis and DNA sequencing. Additional non-medical applications include: gamma ray detectors for homeland security, environmental monitoring, industrial control systems, robotics, biomedical testing, navigation and guidance systems, laser radars and high-energy physics.

The MAPDs will be made available for sale to qualified customers through the company's website. Technical information on the MAPD can be found on the company's website www.zecotek.com/products.

About Zecotek

Zecotek Medical Systems is a photonics technology company developing high-performance crystals, photo detectors, medical lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: imaging systems, laser systems and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending bio-photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.

Stocks in the news and acting well as of late include: Texas Roadhouse Inc. (NASDAQ: TXRH), Sepracor Inc. (NASDAQ: SEPR) and Microsoft Corp. (NASDAQ: MSFT).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis.

Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated fifty thousand dollars from Zecotek Medical Systems Inc. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.

Contact Information